These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21095503)

  • 1. [What's new in acne? New therapeutic approaches].
    Bettoli V; Sarno O; Zauli S; Borghi A; Minghetti S; Ricci M; Mantovani L; Toni G; Virgili A
    Ann Dermatol Venereol; 2010 Nov; 137 Suppl 2():S81-5. PubMed ID: 21095503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer approaches to the treatment of acne vulgaris.
    Simonart T
    Am J Clin Dermatol; 2012 Dec; 13(6):357-64. PubMed ID: 22920095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New and emerging treatments in dermatology: acne.
    Katsambas A; Dessinioti C
    Dermatol Ther; 2008; 21(2):86-95. PubMed ID: 18394082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of acne vulgaris: an evidence-based update.
    Ingram JR; Grindlay DJ; Williams HC
    Clin Exp Dermatol; 2010 Jun; 35(4):351-4. PubMed ID: 19874358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging drugs for acne.
    James KA; Burkhart CN; Morrell DS
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):649-59. PubMed ID: 19772370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of topical retinoids for inflammatory acne: a review of the pharmacoeconomic considerations.
    Harper J
    Manag Care Interface; 2005 Mar; 18(3):51-5. PubMed ID: 15816299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations.
    Dréno B; Bettoli V; Ochsendorf F; Perez-Lopez M; Mobacken H; Degreef H; Layton A
    Eur J Dermatol; 2006; 16(5):565-71. PubMed ID: 17101480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical retinoids in acne--an evidence-based overview.
    Thielitz A; Abdel-Naser MB; Fluhr JW; Zouboulis CC; Gollnick H
    J Dtsch Dermatol Ges; 2008 Dec; 6(12):1023-31. PubMed ID: 18479477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris.
    Stotland M; Shalita AR; Kissling RF
    Am J Clin Dermatol; 2009; 10(4):221-7. PubMed ID: 19489655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel topical drug delivery systems and their potential use in acne vulgaris.
    Taglietti M; Hawkins CN; Rao J
    Skin Therapy Lett; 2008 Jun; 13(5):6-8. PubMed ID: 18648713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acne and systemic disease.
    Lolis MS; Bowe WP; Shalita AR
    Med Clin North Am; 2009 Nov; 93(6):1161-81. PubMed ID: 19932324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical considerations on the use of concomitant therapy in the treatment of acne.
    Alexis AF
    J Dermatolog Treat; 2008; 19(4):199-209. PubMed ID: 18608730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing acne vulgaris effectively.
    Goodman G
    Aust Fam Physician; 2006 Sep; 35(9):705-9. PubMed ID: 16969442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
    Gollnick HP; Graupe K; Zaumseil RP
    Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of dapsone gel 5% in the treatment of acne vulgaris.
    Pickert A; Raimer S
    Expert Opin Pharmacother; 2009 Jun; 10(9):1515-21. PubMed ID: 19505219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution.
    Gold MH; Rao J; Goldman MP; Bridges TM; Bradshaw VL; Boring MM; Guider AN
    J Drugs Dermatol; 2005; 4(1):64-70. PubMed ID: 15696987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open study to determine the efficacy of blue light in the treatment of mild to moderate acne.
    Morton CA; Scholefield RD; Whitehurst C; Birch J
    J Dermatolog Treat; 2005; 16(4):219-23. PubMed ID: 16249142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Topical treatment of acne].
    Auffret N
    Rev Prat; 2002 Apr; 52(8):854-7. PubMed ID: 12053794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phototherapy in the treatment of acne vulgaris.
    Sami NA; Attia AT; Badawi AM
    J Drugs Dermatol; 2008 Jul; 7(7):627-32. PubMed ID: 18664153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.